Welcome message

In reflecting on our latest issue, this month published at the time of the annual European Society of Cardiology annual meeting, we cannot help but appreciate the immense effort that goes into creating – not only our journal, EuroIntervention and the ESC meeting itself – but the collaborative effort in the day-to-day practice of our profession, drawing, as it does, not only from our own speciality, but from other fields and specialities as well. Patrick W. Serruys. Patrick W. Serruys

Focus On

Tissue characterisation of atherosclerotic plaque in coronary artery bifurcations: an intravascular ultrasound radiofrequency data analysis in humans

A study demonstrating that heterogeneous nature of coronary atherosclerosis at coronary bifurcations according to their segments and anatomical locations (LM-LAD vs. non-LM bifurcations) using intravascular ultrasound radiofrequency data.

Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial

In this sub-analysis of the randomised On-Time II trial, pre-hospital administration of tirofiban in diabetic STEMI patients treated with primary PCI improves ST resolution and reduces myocardial infarct size. Tirofiban seems particularly beneficial in patients with diabetes.

Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS)

659 patients with carotid obstructive disease (COD) and concomitant coronary artery disease (CAD),were assessed for 30-day clinical outcome of endovascular and surgical revascularisation procedures.

How should I treat a staggering TAVI procedure?

A 79-year-old female patient with past medical history of chronic myeloid leukaemia, presented to the outpatient cardiology clinic with shortness of breath (NYHAclass 3) and fatigue. Severe calcified aortic valve stenosis by Echocardiography was diagnosed with a logistic EuroSCORE of 10.3. With invited expert opinions from Johan Bosmans and Rüdiger Lange.

Ahead of Print articles

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

Multimodality imaging of the first-in-man trial using fully resorbable everolimus-eluting scaffold (BVS, Abbott Vascular, Santa Clara, CA, USA).Three-year clinical results have demonstrated a sustained low MACE rate (3.4%) without any late complication such as stent thrombosis.

Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study

We investigated the impact of arterial injury on neointimal hyperplasia following implantation of drug-eluting stents (DES)in a total of 196 patients with 223 segments (SES: 104,PES:119) undergoing intravascular ultrasound eight months after DES implantation.

Get Flash to see this player.

Get Flash to see this player.

Online ISSN 1969-6213 - Print ISSN 1774-024X